UHS$228.42
$227.42
Chart
Performance
Key Stats
AI UHS Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
NeutralUniversal Health Services (UHS) shows mixed signals. While its fundamental health is solid with consistent profitability and revenue growth, recent price action indicates significant downside pressure. Technical indicators suggest oversold conditions, hinting at a potential rebound, but the overall market sentiment and recent performance warrant a cautious approach. Consider potential for short-term trading opportunities balanced with long-term fundamental value.
Thematic
UHS operates within the healthcare services sector, which generally benefits from stable demand driven by demographic trends and increasing healthcare needs. However, the sector is also subject to regulatory changes and cost pressures. Current data does not highlight strong unique thematic tailwinds beyond general healthcare demand.
Fundamental
UHS demonstrates robust financial health with strong revenue and earnings growth historically, coupled with a manageable debt level. Profitability metrics are solid, and the company is a consistent dividend payer. The recent price drop may present a buying opportunity for value-oriented investors.
Technical
The stock has experienced a significant decline, trading well below its 52-week high. Technical indicators suggest the stock is currently oversold across multiple timeframes, with some oscillators showing potential for a bounce. However, moving averages and momentum indicators generally signal a bearish trend in the short to medium term.
| Factor | Score |
|---|---|
| Healthcare Demand Growth | 75 |
| Regulatory Environment | 60 |
| Behavioral Health Expansion | 80 |
| Operational Efficiency | 70 |
| Market Competition | 65 |
| Factor | Score |
|---|---|
| Valuation | 85 |
| Profitability | 80 |
| Growth | 70 |
| Balance Sheet Health | 70 |
| Cash Flow | 80 |
| Dividend Yield | 40 |
| Factor | Score |
|---|---|
| Trend Analysis | 30 |
| Momentum | 80 |
| Volume Confirmation | 60 |
| Support & Resistance | 70 |
| Short-Term Oscillators | 75 |
AI Investing Checklist
Powered by LiveAIBullish Points (6)
Consistent EPS Surprises
The company has a strong track record of beating earnings per share (EPS) estimates, with 10 out of the last 12 reported quarters exceeding expectations. The average surprise percentage is positive, indicating reliable earnings performance.
Undervalued P/E Ratio
The trailing Price-to-Earnings (P/E) ratio of 8.73 is significantly lower than the industry average, suggesting the stock may be undervalued given its earnings potential. The P/E ratio for the year 2024 is projected at 9.0.
Bearish Points (8)
High P/S Ratio
The Price-to-Sales (P/S) ratio of 0.8 (TTM) and 0.6 (2024 projection) may be considered high for the healthcare services sector, depending on growth and margin expectations. The quarterly P/S ratios are also elevated.
Slowing Revenue Growth Trend
While FY2024 revenue reached $15.83 billion, the quarterly revenue growth shows a decelerating trend, with Q1 2025 revenue at $4.10 billion, down from $4.11 billion in Q4 2024. This could signal market saturation or increased competition.
Calendar
July 2025
29
Next Earnings Date
H: $5.15
A: $4.94
L: $4.74
H: 4.29B
A: 4.24B
L: 4.17B
September 2025
2
Ex-Dividend Date
September 2025
16
Next Dividend Date
Profile
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. The company was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
Seasonals
Price Target
224.24 USD
The 39 analysts offering 1 year price forecasts for UHS have a max estimate of 280.00 and a min estimate of 185.00.
Debt Level and Coverage
Financial Position Analysis
Ownership
Capital Structure
Valuation - Summary
Valuation - Ratios
Revenue to Profit Conversion
Balance Sheet
Income Statement
Cash Flow
Related Companies
Powered by LiveAIWeight: 98
Direct competitor; one of the largest for-profit operators of acute care hospitals and outpatient facilities in the U.S.
Weight: 95
Direct competitor; leading provider of behavioral healthcare services, a core segment for UHS.
Weight: 92
Direct competitor; operates acute care hospitals, ambulatory surgery centers, and other healthcare facilities.
Weight: 90
Direct competitor; operates general acute care hospitals and related healthcare services across the U.S.